CVS HEALTH CORPORATION Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10
CVS HEALTH CORPORATION (CVS) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 of $5.88 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue · last filed 2026-08-05
- 2026-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 $5.88B.
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 $5.68B.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 $5.38B.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 $4.78B.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 |
|---|---|
| 2026-06-30 | $5.88B 10-Q · filed 2026-08-05 |
| 2026-03-31 | $5.68B 10-Q · filed 2026-05-06 |
| 2025-12-31 | $5.38B 10-K · filed 2026-02-10 |
| 2025-09-30 | $4.78B 10-Q · filed 2025-10-29 |
| 2025-06-30 | $4.56B 10-Q · filed 2025-07-31 |
| 2025-03-31 | $4.38B 10-Q · filed 2025-05-01 |
| 2024-12-31 | $4.58B 10-K · filed 2025-02-12 |
| 2024-09-30 | $4.89B 10-Q · filed 2024-11-06 |
| 2024-06-30 | $4.29B 10-Q · filed 2024-08-07 |
| 2024-03-31 | $4.46B 10-Q · filed 2024-05-01 |
| 2023-12-31 | $4.20B 10-K · filed 2024-02-07 |
| 2023-09-30 | $3.89B 10-Q · filed 2023-11-01 |
| 2023-06-30 | $4.08B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $4.30B 10-Q · filed 2023-05-03 |
| 2022-12-31 | $4.40B 8-K · filed 2023-05-25 |
| 2022-09-30 | $4.35B 10-Q · filed 2022-11-02 |
| 2022-06-30 | $4.56B 10-Q · filed 2022-08-03 |
| 2022-03-31 | $4.96B 10-Q · filed 2022-05-04 |
| 2021-12-31 | $4.91B 10-K · filed 2022-02-09 |
| 2021-09-30 | $4.72B 10-Q · filed 2021-11-03 |
| 2021-06-30 | $4.68B 10-Q · filed 2021-08-04 |
| 2021-03-31 | $4.37B 10-Q · filed 2021-05-04 |
| 2020-12-31 | $4.12B 10-K · filed 2021-02-16 |
| 2020-09-30 | $3.77B 10-Q · filed 2020-11-06 |
| 2020-06-30 | $3.45B 10-Q · filed 2020-08-05 |
| 2020-03-31 | $3.23B 10-Q · filed 2020-05-06 |
| 2019-12-31 | $3.30B 10-K · filed 2020-02-18 |
| 2019-09-30 | $3.32B 10-Q · filed 2019-11-06 |
| 2019-06-30 | $3.35B 10-Q · filed 2019-08-07 |
| 2018-12-31 | $3.00B 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |